3CI LAB2MARKET CONCEPT TO CLINIC COMMERCIALIZING INNOVATION Trademark

Trademark Overview


On Monday, November 28, 2022, a trademark application was filed for 3CI LAB2MARKET CONCEPT TO CLINIC COMMERCIALIZING INNOVATION with the United States Patent and Trademark Office. The USPTO has given the 3CI LAB2MARKET CONCEPT TO CLINIC COMMERCIALIZING INNOVATION trademark a serial number of 97693981. The federal status of this trademark filing is REGISTERED as of Tuesday, February 6, 2024. This trademark is owned by Lab2Market, PBC. The 3CI LAB2MARKET CONCEPT TO CLINIC COMMERCIALIZING INNOVATION trademark is filed in the Education & Entertainment Services category with the following description:

Education services, namely, providing live and on-line courses, classes, lectures, seminars, workshops, and training in the field of commercialization for medical innovation; Educational services, namely, conducting courses, classes, lectures, seminars, workshops, and training in the field of commercialization for medical innovation and distribution of educational materials in connection therewith; Providing educational mentoring services and programs in the field of commercialization for medical innovation
3ci lab2market concept to clinic commercializing innovation

General Information


Serial Number97693981
Word Mark3CI LAB2MARKET CONCEPT TO CLINIC COMMERCIALIZING INNOVATION
Filing DateMonday, November 28, 2022
Status700 - REGISTERED
Status DateTuesday, February 6, 2024
Registration Number7297451
Registration DateTuesday, February 6, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 21, 2023

Trademark Statements


Goods and ServicesEducation services, namely, providing live and on-line courses, classes, lectures, seminars, workshops, and training in the field of commercialization for medical innovation; Educational services, namely, conducting courses, classes, lectures, seminars, workshops, and training in the field of commercialization for medical innovation and distribution of educational materials in connection therewith; Providing educational mentoring services and programs in the field of commercialization for medical innovation
Description of MarkThe mark consists of the literal element "3Ci" above the literal element "Lab2Market" in stylized wording with the "2" having three diagonal slashes. Underneath is the wording "CONCEPT TO CLINIC" stacked above the wording "COMMERCIALIZING INNOVATION".
Pseudo MarkTHREE CONCEPT INNOVATION LAB TWO MARKET CONCEPT TO CLINIC COMMERCIALIZING INNOVATION; THREE CLINIC INNOVATION LAB TO MARKET CONCEPT TO CLINIC COMMERCIALIZING INNOVATION; THREE COMMERCIALIZING INNOVATION LAB TWO MARKET CONCEPT TO CLINIC COMMERCIALIZING INNOVATION
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, December 20, 2022
Primary Code041
First Use Anywhere DateMonday, August 15, 2022
First Use In Commerce DateThursday, September 1, 2022

Trademark Owner History


Party NameLab2Market, PBC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDana Point, CA 92629

Party NameLab2Market, PBC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDana Point, CA 92629

Party NameLab2Market, PBC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDana Point, CA 92629

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 6, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 13, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 13, 2023NON-FINAL ACTION WRITTEN
Thursday, September 7, 2023ASSIGNED TO EXAMINER
Wednesday, December 21, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 1, 2022NEW APPLICATION ENTERED